yes, I meant Disbrow.
Please read the post SEC filing Dec 19th. I posted it in case you can't find it this morning-- it's an attachment AMPIO made to the filing. It's long and at the very end it shows Disbrow's milestones he must reach in order to vest his options.
It is both good and bad. Good in that it shows that the company plans to get the stock to $5 within 6 months of the filing of the Dec 19th form. Bad in the sense it will be further dilution of shares. And that is not to mention the unstated intentions of management to sell their shares.
I have no idea of Disbrow's connections with mutual funds/retirement funds managers to get this much money. No connections with ivy league graduates, but with someone(s) since he's done this with the previous company he has worked for.
Agree about good/bad. $15M at $5 per is 3M shares... a little less than 10% dilution. It is dilution, but with a potential double, triple or quadruple, if things go well with one, two or three drugs, less than a 10% dilution isn't too bad.
I just hope having this stupid RKTE chart on the message board is not prophetic!